I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment success results among AN/AI (sustained virologic ..:
Lisa Townshend-Bulson (222003)
;
Elena Roik (11785791)
;
Youssef Barbour (11785794)
...
https://figshare.com/articles/dataset/Treatment_success_results_among_AN_AI_sustained_virologic_response_at_12_weeks_post_treatment_by_intention-to-treat_and_per-protocol_analyses_with_95_confidence_intervals_CI_Alaska_treated_March_2014-_December_2018_/17117697. , 2021
Link:
https://doi.org/10.1371/journal.pone.0260970.t003
RT Journal T1
Treatment success results among AN/AI (sustained virologic response at 12 weeks post treatment) by intention-to-treat and per-protocol analyses with 95% confidence intervals [CI], Alaska, treated March 2014- December 2018
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17117697&Exemplar=1&LAN=DE A1 Lisa Townshend-Bulson (222003) A1 Elena Roik (11785791) A1 Youssef Barbour (11785794) A1 Dana J. T. Bruden (11785797) A1 Chriss E. Homan (11785800) A1 Hannah G. F. Espera (11785803) A1 Timothy J. Stevenson (11785806) A1 Annette M. Hewitt (11785809) A1 Wileina Rhodes (11785812) A1 James E. Gove (11785815) A1 Julia N. Plotnik (11785818) A1 Mary M. Snowball (11785821) A1 John McGilvray (11785824) A1 Brenna C. Simons (11785827) A1 Janet M. Johnston (11785830) A1 Brian J. McMahon (11785833) YR 2021 K1 Medicine K1 Pharmacology K1 Biotechnology K1 Cancer K1 Mental Health K1 Infectious Diseases K1 Plant Biology K1 Virology K1 Computational Biology K1 Chemical Sciences not elsewhere classified K1 sustained virologic response K1 infectious disease society K1 confirmed positive anti K1 common symptom experienced K1 sofosbuvir plus weight K1 3 &# 8211 K1 hepatitis c treatment K1 alaska native people K1 one discontinued sofosbuvir K1 genotype 3 91 K1 american indian experience K1 xlink "> direct K1 three daa regimens K1 real life setting K1 included 501 patients K1 ai patients within K1 treatment efficacy based K1 xlink "> K1 alaska native K1 american indian K1 based regimens K1 based direct K1 world setting K1 received one K1 based treatment K1 american association K1 hcv genotype K1 ai patients K1 based ribavirin K1 treatment outcomes K1 treatment completion K1 well tolerated K1 velpatasvir due K1 range 21 K1 myocardial infarction K1 liver diseases K1 limited data K1 joint pain K1 high regardless K1 given according JF https://figshare.com/articles/dataset/Treatment_success_results_among_AN_AI_sustained_virologic_response_at_12_weeks_post_treatment_by_intention-to-treat_and_per-protocol_analyses_with_95_confidence_intervals_CI_Alaska_treated_March_2014-_December_2018_/17117697 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0260970.t003 DO https://doi.org/10.1371/journal.pone.0260970.t003 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)